Moderna to start local production of Covid-19 mRNA vaccine in Canada

Moderna to start local production of Covid-19 mRNA vaccine in Canada

 

 

Moderna Inc said on Tuesday it had agreed with the Canadian government to start domestic production of mRNA vaccines; as the country looks to boost supplies to fight respiratory viruses; including Covid-19 and seasonal influenza.

 

Under the memorandum of understanding; Moderna will set up an mRNA vaccine manufacturing facility in Canada; and also give access to its mRNA development engine.

 

The Covid-19 vaccine from Moderna, based on mRNA technology; is already being used in the United States, the European Union, and Canada.

 

Scientists believe mRNA has the potential to target diseases that cannot be reached by conventional drugs. Such vaccines; which have shown high efficacy in preventing Covid-19 disease; contain no actual virus, instead providing instructions for human cells to make proteins that mimic part of the coronavirus.

ALSO READ: Pfizer, Moderna vaccines linked to ‘extremely rare risk’ of heart inflammation

 

 

Last week, Moderna said its Covid-19 shot was about 93% effective through six months after the second dose; showing hardly any change from the 94% efficacy reported in its original clinical trial.

 

Canada has reported 1.4 million infections and 26,678 coronavirus-related deaths; since the pandemic began, according to Reuters tally.

 

The manufacturing facility is expected to be activated on an urgent basis to support Canada with direct access to rapid pandemic response capabilities; Moderna said on Tuesday, also adding that it is in talks with other governments about potential collaborations.

About The Author

Osigweh Lilian Oluchi is a graduate of the University of Lagos where she obtained a B.A (Hons) in English, Masters in Public and International affairs (MPIA). Currently works with 1stnews as a Database Manager / Writer. [email protected]

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *